Lipe & Dalton Idexx Laboratories Inc Transaction History
Lipe & Dalton
- $202 Million
- Q4 2025
A detailed history of Lipe & Dalton transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Lipe & Dalton holds 790 shares of IDXX stock, worth $545,044. This represents 0.26% of its overall portfolio holdings.
Number of Shares
790Holding current value
$545,044% of portfolio
0.26%Shares
1 transactions
Others Institutions Holding IDXX
# of Institutions
1,476Shares Held
73.9MCall Options Held
249KPut Options Held
199K-
Vanguard Group Inc Valley Forge, PA9.96MShares$6.87 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$6.63 Billion0.11% of portfolio
-
State Street Corp Boston, MA3.52MShares$2.43 Billion0.08% of portfolio
-
Terry Smith Fundsmith LLP | London, X02.61MShares$1.8 Billion8.47% of portfolio
-
Geode Capital Management, LLC Boston, MA2.5MShares$1.72 Billion0.11% of portfolio
About IDEXX LABORATORIES INC
- Ticker IDXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 83,253,696
- Market Cap $57.4B
- Description
- IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...